NASDAQ:NRSNW

NeuroSense Therapeutics Ltd.

Read NRSNW's Filings Free

Company facts

Headquarters
Herzliya
Most recent report
6-K, filed Aug 13, 2026
Filings on record
306 filings
On EDGAR
CIK 1875091
Fiscal year ends
December
Filer status
Non-accelerated filer Emerging growth company

Financials 8 of 170

Prospectuses and Registrations 8 of 47

Ownership 8 of 25

Other 8 of 64

Everything here comes from NeuroSense Therapeutics Ltd.'s own filings on SEC EDGAR. The filing list is rechecked every hour.